New therapeutic options being currently investigated in advanced or metastatic colorectal cancer
New therapeutic options being currently investig
Anti-PD-1 compounds targeting MSI-H/dMMR tumors
Anti-PD-1 compounds targeting MSI-H/dMMR tumors
PARP- and anti-PD-1-based strategies in breast and cervical cancer
PARP- and anti-PD-1-based strategies in breast a
Checkpoint inhibition: predictors, resistance and immunogenomic features
Checkpoint inhibition: predictors, resistance an
Novel approaches in gastric cancer
Novel approaches in gastric cancer LEAP-005:
Roberto Pazo-Cid
ASCO 2021 Solid Tumors - Roberto Pazo-Cid Roberto
多种实体瘤中的新型组合方法
多种实体瘤中的新型组合方法 乐伐替尼（lenvatinib）加派姆单抗 抗血管生成多激酶
卵巢癌：将PARP抑制更进一步
卵巢癌：将PARP抑制更进一步 尼拉帕利（niraparib）的个性化用量 根据NOVA
将创新从实验室带入临床实践
将创新从实验室带入临床实践 Andrés Cervantes, MD, PhD, 西班牙
胃癌和食管癌中PD-1抑制取得的里程碑式进展
胃癌和食管癌中PD-1抑制取得的里程碑式进展 胃癌、胃食管连接部（GEJ）腺癌和食道腺癌
